[1]
|
Zi, M. and Xu, Y. (2018) Involvement of Cystatin C in Immunity and Apoptosis. Immunology Letters, 196, 80-90.
https://doi.org/10.1016/j.imlet.2018.01.006
|
[2]
|
Kar, S., Paglialunga, S. and Islam, R. (2018) Cystatin C Is a More Reliable Biomarker for Determining eGFR to Support Drug Development Studies. Journal of Clinical Pharmacology, 58, 1239-1247. https://doi.org/10.1002/jcph.1132
|
[3]
|
刘宁, 成金钟, 陈亚巍. 测定慢性肾小球肾炎患者血清胱抑素C水平的变化及意义[J]. 中华保健医学杂志, 2012, 14(2): 150-152.
|
[4]
|
赵帆, 张枚, 何訸, 等. 糖尿病肾病患者血清胱抑素C和尿微量白蛋白检测水平分析[J]. 中国实验诊断学, 2018, 22(10): 1711-1714.
|
[5]
|
Satirapoj, B. (2018) Tubulointerstitial Biomarkers for Diabetic Nephropathy. Journal of Diabetes Research, 2018, Article ID: 2852398. https://doi.org/10.1155/2018/2852398
|
[6]
|
Elsayed, M.S., El Badawy, A., Ahmed, A., et al. (2019) Serum Cystatin C as an Indicator for Early Detection of Diabetic Nephropathy in Type 2 Diabetes Mellitus. Diabetes & Metabolic Syndrome, 13, 374-381.
https://doi.org/10.1016/j.dsx.2018.08.017
|
[7]
|
杨建宝, 李金巍. 高血压肾病患者的中性粒细胞明胶酶相关脂质运载蛋白、胱抑素C、肌酐、尿素氮水平及其临床意义研究[J]. 中国临床医生杂志, 2018, 46(4): 408-410.
|
[8]
|
蒋琰, 刘如石, 李原, 等. 血清胱抑素C、同型半胱氨酸联合检测对诊断高血压早期肾病的意义[J]. 重庆医学, 2015, 44(9): 1193-1196.
|
[9]
|
Bhavsar, N.A., Appel, L.J., Kusek, J.W., et al. (2011) Comparison of Measured GFR, Serum Creatinine, Cystatin C, and Beta-Trace Protein to Predict ESRD in African Americans with Hypertensive CKD. American Journal of Kidney Diseases, 58, 886-893. https://doi.org/10.1053/j.ajkd.2011.07.018
|
[10]
|
Naito, Y., Sawada, H., Oboshi, M., et al. (2013) Increased Renal Iron Accumulation in Hypertensive Nephropathy of Salt-Loaded Hypertensive Rats. PLoS ONE, 8, e75906. https://doi.org/10.1371/journal.pone.0075906
|
[11]
|
Tylicki, L. and Rutkowski, B. (2003) Hypertensive Nephropathy: Pathogenesis, Diagnosis and Treatment. Polski merkuriusz lekarski: Organ Polskiego Towarzystwa Lekarskiego, 14, 168-173.
|
[12]
|
Wali, U., Hussain, M.M., Wali, N., et al. (2019) Comparison of Serum Levels of Cystatin-C and Traditional Renal Biomarkers for the Early Detection of Pre-Hypertensive Nephropathy. Journal of Pakistan Medical Association, 69, 313-319.
|
[13]
|
武敏, 黄传兵, 贾建云, 等. 胱抑素C在系统性红斑狼疮肾损害中的研究概况[J]. 中医药临床杂志, 2015, 27(1): 17-20.
|
[14]
|
赵秀芬, 黄智敏, 钱军, 等. 血清胱抑素C与IgA肾病Lee氏病理分级的相关性[J]. 江苏医药, 2016, 42(23): 2553-2555.
|
[15]
|
向莉, 周华, 李旻, 等. 胱抑素C评估IgA肾病患者肾纤维化程度及早期肾损害的价值[J]. 江苏医药, 2012, 38(16): 1899-1901.
|
[16]
|
Peixoto, L., Aguiar, P., de Braganca, R., et al. (2015) Cystatin C: A Promising Marker of Renal Function in Patients with Systemic Lupus Erythematosus? Acta Médica Portuguesa, 28, 333-341. https://doi.org/10.20344/amp.5770
|
[17]
|
Kokkoris, S., Pipili, C., Grapsa, E., et al. (2013) Novel Biomarkers of Acute Kidney Injury in the General Adult ICU: A Review. Renal Failure, 35, 579-591. https://doi.org/10.3109/0886022X.2013.773835
|
[18]
|
Fouad, M. and Boraie, M. (2013) Cystatin C as an Early Marker of Acute Kidney Injury and Predictor of Mortality in the Intensive Care Unit after Acute Myocardial Infarction. Arab Journal of Nephrology and Transplantation, 6, 21-26.
|
[19]
|
Leem, A.Y., Park, M.S., Park, B.H., et al. (2017) Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery. Yonsei Medical Journal, 58, 604-612.
https://doi.org/10.3349/ymj.2017.58.3.604
|
[20]
|
Beker, B.M., Corleto, M.G., Fieiras, C., et al. (2018) Novel Acute Kidney Injury Biomarkers: Their Characteristics, Utility and Concerns. International Urology and Nephrology, 50, 705-713. https://doi.org/10.1007/s11255-017-1781-x
|